Search

You searched for "orbital"

2226 results found

Advocacy on the Airwaves: Pioneering eye health partnership doubles sight-saving child screenings in Zambian Province

20 November 2025 | international, charity, patient stories, public health
A pioneering eye health programme is creating a legacy for children in Zambia, having almost doubled access to sight-saving eye screenings in its first two years of operation. Working in the heart of Zambia’s Copperbelt Province, the Qatar Creating Vision...

Supporting the next generation of ophthalmologists. That’s Newmedica.

5 December 2025
Independent provider Newmedica offers placements in centres nationwide, supporting ophthalmologists in training. Both trainees and consultants have noted the benefits for patients and the NHS, with the North East programme as a prime example. Dr Oonagh Crothers, a fifth year...

Learning from litigation: ocular drug toxicity

3 August 2023 | | EYE - General
Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the sword of Damocles above us...

Management of proliferative diabetic retinopathy

1 August 2014 | | EYE - Vitreo-Retinal
Diabetic retinopathy is a major cause of blindness in the working-age population. Due to the worsening global epidemic of diabetes, the incidence of morbidity caused by the disease is set to increase [1]. The prevalence of diabetes in the UK...

My experience of the transition into a specialist orthoptist role

1 August 2018 | | EYE - General
Michelle Dent discusses the process of transitioning into a new role and the pros and cons along the way. An opportunity arose for a permanent, full time, band 7 specialist role in the medical retina (MR) team in the Newcastle...

Sustainability in eyecare: Intraocular gases and the climate emergency

4 August 2021 | | EYE - Vitreo-Retinal, EYE - General
In 2020 the NHS became the first national health system to commit to delivering ‘net zero’ carbon emissions by 2040. The author investigates how the impact of ophthalmic surgery can be reduced. Medical gases have been used in ophthalmic surgery...

Ocular manifestations of multiple sclerosis: an overview

1 December 2022 | | EYE - Neuro-ophthalmology, EYE - Pathology
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS), in which there is dissemination of lesions in time (two or more clinical events) and space (multiple lesions seen on brain and spinal imaging). The pathophysiology...

ChatGPT cannot pass FRCOphth examinations: implications for ophthalmology and large language model artificial intelligence

26 April 2023 | | EYE - General
Large language models are generating a lot of hype for artificial intelligence, but can they assist patients and practitioners in ophthalmology? Introduction Deep learning (DL) has emerged in ophthalmology as an exciting form of artificial intelligence (AI) most commonly applied...

Two cases of acute syphilitic posterior placoid chorioretinitis

4 December 2025 | | EYE - Imaging, EYE - Vitreo-Retinal
Syphilis has re-emerged as a significant public health concern, with the World Health Organization (WHO) estimating that 8 million adults aged 15–49 acquired syphilis in 2022. Untreated syphilis can have severe consequences, including cardiovascular, neurological and ocular complications. Ocular manifestations...

IN FOCUS - VISION 2020 LINKS Programme: the contribution of health partnerships to reduction in blindness worldwide

1 April 2020 | | EYE - General
As other articles in this series (IN FOCUS Apr 2020) demonstrate, the year 2020 is highly significant in the eye care field. Naming a global initiative ‘VISION 2020: The Right to Sight’ in 1999 was a daring way to focus...

Management of diabetic macular oedema in vitrectomised eyes

1 August 2016 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is one of the leading causes of blindness; its prevalence is on the rise with progressive increase in numbers of people suffering from diabetes. The management of DMO has evolved significantly over the past few years....

Optimising the ocular surface by managing meibomian gland dysfunction

1 February 2016 | | EYE - Cornea
Meibomian gland dysfunction (MGD) is ubiquitous. Ocular surface inflammation and irritation are prevalent in most ophthalmology clinics: corneal, cataract, glaucoma, oculoplastic, paediatric, vitreo-retinal, medical retina and refractive surgery. These patients also represent roughly one third of those attending for emergency...